Question special
Lead Moderator

The discussion article comments that antibiotics are a “precious finite resource that should be conserved”. Do you feel that reducing antibiotic prescribing is at odds with drug development and manufacturing? How can we effectively fund the development of novel antibiotics and secure stable supplies of current antibiotics, while limiting use?